Please assess the completion status of the following clinical trial:

Trial Title: Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients newborn to 18 years old.~* Patients with intraocular retinoblastoma, unilateral or bilateral, who would be treated either by systemic chemotherapy, EBR, or enucleation would be considered for this study.~Exclusion Criteria:~* Patients over the age of 18.~* Patients with small, localized intraocular Rb amenable to focal therapy (laser or cryotherapy).~* Patients with extraocular disease evident on MRI (extension into the optic nerve), massive choroidal/uveal invasion (grade IIC or IID per ARET0332) or disease outside the globe evident on MRI or physical examination.~* Documented hypercoagulable disorders or vasculopathies.~* Laboratory exclusion criteria: GFR \< 60 mL/min/1.73 m2

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Intraocular Retinoblastoma Patients (Type: OTHER): Single group assignment of patients with intraocular retinoblastoma, unilateral or bilateral.

Based on this trial design, predict the completion outcome and termination type (if applicable).